DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Greenway FL, Fujioka K, Plodkowski RA. et al; COR-I Study Group.
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet 2010;
376 (9741): 595-605
We do not assume any responsibility for the contents of the web pages of other providers.